← All themes
Theme

Managed Care

Every analyzed stock in Managed Care13 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Managed Care risk
Near-term vs. long-term risk for this theme
⚡ Right now ?Near-term risk over roughly the next 3 months. Blends live market conditions (volatility, how far the S&P is from its highs, credit spreads, the yield curve, sentiment), how stretched valuations are, and what the smart money is doing. Higher = greater odds of a pullback. · next 0–3 months
46 /100 Elevated ▼ -6 mild
Long-term risk ?Long-term / structural risk — the market's underlying tide. Where valuations sit versus 145 years of history (Shiller CAPE) plus multi-year trends. A high reading means weak long-run return prospects even if the market feels calm right now. · structural · vs 145yr history
65 /100 High ◆ flat
▲ / ▼ = change vs ~7 days ago — red = risk rising, green = falling.
Inside the "right now" score — a 45 / 30 / 25 blend · 11 stocks valued
Conditions · 45% ?The live market weather: VIX (expected volatility), how far the S&P 500 is below its 52-week high, high-yield credit spreads, the 10-year vs 2-year yield curve, and the Fear & Greed index. Market-wide indices, not per-stock.
35 Moderate
Valuation · 30% ?How expensive stocks are versus our intrinsic-value models: the median price-to-value ratio and the share of stocks trading above what we think they are worth, across 11 stocks.
48 Elevated
Smart money · 25% ?What informed money is doing: short-selling activity plus corporate insiders buying or selling their own stock. Broken out below.
58 Elevated
Smart money — the three inputs
Short-selling ?Share of ALL US trading volume that is short sales (FINRA, ~12,000 symbols, market-wide). It normally sits near 45–50%, so readings above ~50% lean bearish and read as higher risk. Weighted 40% of Smart money.
52.0%
Elevated
Insider data still collecting — showing market-wide short-selling only. Fill it via Admin → Risk Alerts → "Drain the whole universe".
Smart money is showing the neutral market-wide short-selling reading — the insider buyers'-strike signal turns on once the data finishes collecting (Admin → Risk Alerts → "Collect smart-money now" or "Drain the whole universe").
Long-term risk: the long-term read runs high mainly because valuations sit near a historic extreme (Shiller CAPE) — a structural backdrop, not about this week.
Divergence: insiders are defensive while macro conditions (credit, curve, volatility) stay calm. Insiders are strong judges of their own companies but poor macro timers — historically this pattern favors selective stock-picking (see the opportunistic-buy signals) over exiting the market wholesale.
Scale (0–100): 0–20 Low · 20–40 Moderate · 40–60 Elevated · 60–80 High · 80–100 Extreme. "Right now" reads today's conditions; the "long-term" score is anchored to ~145 years of valuation history.
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ALHC
Alignment Healthcare, Inc.
Valuation N/A
Financial Services Risk 58 · Elevated
Price$12.61
Model IV
P/IV
Limited data — see page
ASTH
Astrana Health, Inc.
Deeply overvalued
Industrials Risk 60 · High
Price$37.98
Model IV$26.89
P/IV1.40
Premium +41% Return to IV: -29.2%
Market implies +23.7%/yr vs model +25.0% · in line
BTSGU
BrightSpring Health Services, Inc.
Fairly valued
Healthcare Risk 68 · High
Price$194.08
Model IV$187.63
P/IV1.03
Premium +3% Return to IV: -3.3%
Market implies -2.1%/yr vs model +18.7% · below model
CI
Cigna Group
Deeply overvalued
Financial Services Risk 69 · High
Price$280.76
Model IV$209.24
P/IV1.33
Premium +34% Return to IV: -25.5%
CNC
CENTENE CORP
Deeply overvalued
Financial Services Risk 73 · High
Price$66.42
Model IV$32.02
P/IV1.86
Premium +107% Return to IV: -51.8%
CVS
CVS HEALTH Corp
Deeply undervalued
Consumer Cyclical Risk 32 · Moderate
Price$94.66
Model IV$187.57
P/IV0.52
Discount 50% Return to IV: +98.2%
Market implies -1.1%/yr vs model +9.3% · below model
DCGO
DocGo Inc.
Deeply undervalued
Healthcare Risk 29 · Moderate
Price$0.35
Model IV$1.03
P/IV0.54
Discount 66% Return to IV: +191.9%
Market implies -18.8%/yr vs model +3.2% · below model
DVA
DAVITA INC.
Deeply undervalued
Healthcare Risk 39 · Moderate
Price$181.55
Model IV$590.72
P/IV0.33
Discount 69% Return to IV: +225.4%
Market implies -6.6%/yr vs model +9.9% · below model
ELV
Elevance Health, Inc.
Overvalued
Financial Services Risk 53 · Elevated
Price$418.72
Model IV$357.76
P/IV1.10
Premium +17% Return to IV: -14.6%
HUM
HUMANA INC
Fairly valued
Financial Services Risk 50 · Elevated
Price$409.80
Model IV$268.56
P/IV1.14
Premium +53% Return to IV: -34.5%
MOH
MOLINA HEALTHCARE, INC.
Fairly valued
Financial Services Risk 38 · Moderate
Price$204.23
Model IV$184.94
P/IV0.94
Premium +10% Return to IV: -9.4%
TOI
Oncology Institute, Inc.
Deeply undervalued
Healthcare Risk 34 · Moderate
Price$6.20
Model IV$10.83
P/IV0.43
Discount 43% Return to IV: +74.6%
Market implies -7.6%/yr vs model +25.5% · below model
TOIIW
Oncology Institute, Inc.
Valuation N/A
Healthcare Risk 57 · Elevated
Price$0.05
Model IV
P/IV
Market implies -50.0%/yr vs model +25.5% · below model